Scout | Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)

This grant opportunity aims to support promising early-career researchers focused on the chemistry and pharmacology of substance use disorders. It targets those without preliminary data for an R01 grant but who propose impactful research and show leadership potential in the field. The grant encourages innovative research utilizing new methods and technologies to explore novel targets, mechanis…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Award

Award Ceiling: $300,000

Funding Amount: $300,000

Dates

Opportunity Released: October 20, 2022

Open for Submission: October 20, 2022

Submission Deadline: August 7, 2025

Application Window Closes: August 7, 2025

Keywords

early-stage investigators

chemistry

pharmacology

substance use disorders

drug discovery

therapeutic agents

novel targets

research funding

emerging technologies

innovative research

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers